Pay in 4 interest-free payments of $45.00 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
KPV (10mg)
and Thymosin α-1 (5mg)
DAC modification extends half-life significantly vs
and extracellular matrix protein synthesis research
Research interest in this dual-peptide combination focuses on complementary cellular signalling pathways involved in tissue remodelling
BPC-157 · 20mg Research Vial dsip KPV (10mg)FOR RESEARCH USE ONLY NOT FOR HUMAN CONSUMPTION BPC 157 (Body Protection Compound 157) 20mg high concentration research vial. A synthetic pentadecapeptide extensively studied in in vitro models for angiogenic signalling, VEGFR2 pathway activation, fibroblast proliferation, and extracellular matrix remodelling research. Ideal for bulk in vitro laboratory applications requiring maximum compound per vial. Manufactured to 98% purity by HPLC. Independent
